Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
D000818:Animals; D000951:Antigens, Neoplasm; D002273:Carcinogens; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D007114:Immunization; D008198:Lymph Nodes / Q000276:immunology* / Q000378:metabolism; D008297:Male; D008748:Methylcholanthrene; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology*; D012513:Sarcoma, Experimental / Q000139:chemically induced / Q000276:immunology*; D013154:Spleen / Q000276:immunology* / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism*; D014184:Transplantation, Homologous; D014316:Tritium
D000951:Antigens, Neoplasm; D002273:Carcinogens; D004273:DNA, Neoplasm; D014316:Tritium; D008748:Methylcholanthrene; D013936:Thymidine